This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Avelos Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ja Heouk Khoo: Innovator in Pharmaceutical Compounds
Introduction: Ja Heouk Khoo is a notable inventor based in Gunpo-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific medical conditions. His work focuses on innovative solutions that can potentially improve treatment outcomes for patients.
Latest Patents: Khoo holds a patent for the "Preparation of substituted 1,2-diaminoheterocyclic compound derivatives and their use as pharmaceutical agents." This invention pertains to compounds that act as microtubule associated serine/threonine-like kinase (MASTL) inhibitors. The compounds are designed for use in treating diseases and medical conditions mediated by MASTL, including cancer and other related diseases.
Career Highlights: Khoo is currently associated with Avelos Therapeutics Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cancer treatment and other therapeutic areas.
Collaborations: Some of Khoo's notable coworkers include Ki Seon Baek and Soongyu Choi, who contribute to the collaborative efforts in their research initiatives.
Conclusion: Ja Heouk Khoo's innovative work in pharmaceutical compounds exemplifies the importance of research in developing effective treatments for serious medical conditions. His contributions are paving the way for advancements in cancer therapy and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile